Geno J. Merli, MD; Howard H. Weitz, MD
Disclosures: Geno J. Merli, MD, reports the following: Research grants/contracts: Bristol-Myers Squibb, Bayer. Howard H. Weitz, MD, reports that he has no financial relationships or interests to disclose.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Proctor & Gamble, Pfizer, and Johnson & Johnson.
Cynthia Kuttner, M.D.
VA, Chillicothe Ohio
February 17, 2019
Intensification of treatment for CAD
You didn't comment on what you would do--perhaps a statin and aspirin? Also I wonder if the hemoglobin A1C of 5.6 is now too low and if you would back off on the dose of metformin?
VA Chillicothe, Ohio
Donepezil
Donepezil's GI side effects often outweigh the benefits, would suggest a trial and consider discontinuation if it is not helping cognition and causing GI or cardiac side effects. As a geriatrician, I have not seen much benefit
Merli GJ, Weitz HH. Annals Consult Guys - New Right Bundle Branch Block and Newly Diagnosed Alzheimer's: What to Do?. Ann Intern Med. 2018;169:CG1. doi: https://doi.org/10.7326/W18-0027
Download citation file:
© 2020
Published: Ann Intern Med. 2018;169(12):CG1.
DOI: 10.7326/W18-0027
Cardiology, Dementia, Neurology, Rhythm Disorders and Devices.
Results provided by: